The Anti-Inflammatory Effect of Low Molecular Weight Fucoidan from Sargassum siliquastrum in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via Inhibiting NF-κB/MAPK Signaling Pathways
Marine Drugs · 2023
DOI: 10.3390/md21060347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Arachchige Maheshika Kumari Jayasinghe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Technology and Nutrition, Chonnam National University, Yeosu 59626, Republic of Korea. Hauptthemen laut MEDLINE: NF-kappa B, Sargassum. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Oceans and Fisheries.
Abstract (Originalsprache)
Brown seaweed is a rich source of fucoidan, which exhibits a variety of biological activities. The present study discloses the protective effect of low molecular weight fucoidan (FSSQ) isolated from an edible brown alga, Sargassum siliquastrum, on lipopolysaccharide (LPS)-stimulated inflammatory responses in RAW 264.7 macrophages. The findings of the study revealed that FSSQ increases cell viability while decreasing intracellular reactive oxygen species production in LPS-stimulated RAW 264.7 macrophages dose-dependently. FSSQ reduced the iNOS and COX-2 expression, inhibiting the NO and prostaglandin E2 production. Furthermore, mRNA expression of IL-1β, IL-6, and TNF-α was downregulated by FSSQ via modulating MAPK and NF-κB signaling. The NLRP3 inflammasome protein complex, including NLRP3, ASC, and caspase-1, as well as the subsequent release of pro-inflammatory cytokines, such as IL-1β and IL-18, release in LPS-stimulated RAW 264.7 macrophages was inhibited by FSSQ. The cytoprotective effect of FSSQ is indicated via Nrf2/HO-1 signaling activation, which is considerably reduced upon suppression of HO-1 activity by ZnPP. Collectively, the study revealed the therapeutic potential of FSSQ against inflammatory responses in LPS-stimulated RAW 264.7 macrophages. Moreover, the study suggests further investigations on commercially viable methods for fucoidan isolation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Technology and Nutrition, Chonnam National University, Yeosu 59626, Republic of Korea.
- Department of Agricultural, Food and Nutritional Science, University of Alberta, 4-10 Ag/For Building, Edmonton, AB T6G 2P5, Canada.
- Chuncheon Center, Korea Basic Science Institute (KBSI), Chuncheon 24341, Republic of Korea.
- Food Safety and Processing Research Division, National Institute of Fisheries Science, Busan 46083, Republic of Korea.
- Department of Marine Bio-Food Sciences, Chonnam National University, Yeosu 59626, Republic of Korea.
ORCID-Profile: Arachchige Maheshika Kumari Jayasinghe, Kirinde Gedara Isuru Sandanuwan Kirindage, Ilekuttige Priyan Shanura Fernando, Kil-Nam Kim, Jae-Young Oh
Förderung
- Ministry of Oceans and Fisheries
Zitieren
APA
Jayasinghe, A. M. K., Kirindage, K. G. I. S., Fernando, I. P. S., Kim, K. N., Oh, J. Y., & Ahn, G. (2023). The Anti-Inflammatory Effect of Low Molecular Weight Fucoidan from Sargassum siliquastrum in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via Inhibiting NF-κB/MAPK Signaling Pathways. Marine Drugs. https://doi.org/10.3390/md21060347
Vancouver
Jayasinghe AMK, Kirindage KGIS, Fernando IPS, Kim KN, Oh JY, Ahn G. The Anti-Inflammatory Effect of Low Molecular Weight Fucoidan from Sargassum siliquastrum in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via Inhibiting NF-κB/MAPK Signaling Pathways. Marine Drugs. 2023. doi:10.3390/md21060347
BibTeX
@article{Jayasinghe2023,
author = {Jayasinghe, Arachchige Maheshika Kumari and Kirindage, Kirinde Gedara Isuru Sandanuwan and Fernando, Ilekuttige Priyan Shanura and Kim, Kil-Nam and Oh, Jae-Young and Ahn, Ginnae},
title = {The Anti-Inflammatory Effect of Low Molecular Weight Fucoidan from Sargassum siliquastrum in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via Inhibiting NF-κB/MAPK Signaling Pathways},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21060347}
}
EUVIMED